The effect of prophylactic balloon occlusion in patients with placenta accreta spectrum: a Bayesian network meta-analysis

Dai, Mengjun; Zhang, Fangqin; Li, Kangbo; Jin, Guangxin; Chen, Yidan; Zhang, Xuebin

doi:10.1007/s00330-021-08423-6

Cited by 15 publications

(8 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Bayesian network meta-analysis was performed using R 4.1 software with gemtc and rjags packages as previously described (10). The network meta-analysis employed OR and 95% credibility intervals (95% CrIs).…”

Section: Discussionmentioning

confidence: 99%

The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis

Chen

Lin

et al. 2022

Front. Endocrinol.

View full text Add to dashboard Cite

AimsThis study aimed to assess the impact of different antidiabetic agents on individuals with diabetes and COVID-19.MethodsWe searched PubMed, Web of Science, Embase, and Cochrane Library databases from inception to October 31, 2021 and included seven antidiabetic agents. The data were pooled via traditional pairwise meta-analysis and Bayesian network meta-analysis.ResultsThe pairwise meta-analysis included 35 studies. Metformin (odds ratio (OR), 0.74; P=0.001), dipeptidyl peptidase-4 inhibitors (DPP4i) (OR, 0.88; P=0.04), sodium-glucose cotransporter-2 inhibitors (SGLT2i) (OR, 0.82; P=0.001), and glucagon-like peptide-1 receptor agonists (GLP1RA) (OR, 0.91; P=0.02) treatment were associated with lower COVID-19 mortality in individuals with diabetes compared to respective non-users. However, insulin treatment resulted in higher mortality (OR, 1.8; P=0.001). Mortality did not significantly differ in sulfonylurea (OR, 0.97; P=0.56) and thiazolidinediones (TZDs) (OR, 1.00; P=0.96) users. Furthermore, due to limited data, we analyzed five antidiabetic agents (metformin, DPP4i, sulfonylurea, insulin, and SGLT2i) and found no association between them and severe disease risk (all P>0.05). The Bayesian network meta-analysis included 18 studies. GLP1RA and SGLT2i had the highest first and second rank probability (67.3% and 62.5%, respectively). Insulin showed the maximum probability of ranking seventh (97.0%). Metformin had the third and fourth highest rank probability of 44.8% and 38.9%, respectively. Meanwhile, DPP4i had the fifth-highest rank probability of 42.4%, followed by sulfonylurea at 45.1%.ConclusionMetformin, DPP4i, SGLT2i, and GLP1RA treatments were highly possible to reduced COVID-19 mortality risk in individuals with diabetes, while insulin might be related to increased mortality risk. Sulfonylurea and TZDs treatments were not associated with mortality. None of the antidiabetic agents studied were associated with the risk of severe disease. Additionally, GLP1RA probably had the most significant protective effect against death, followed by SGLT2i and metformin.Systematic Review RegistrationPROSPERO (CRD42021288200)

show abstract

Section: Discussionmentioning

confidence: 99%

The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis

Chen

Lin

et al. 2022

Front. Endocrinol.

View full text Add to dashboard Cite

show abstract

“…98,99 A randomized controlled trial of internal iliac artery occlusion balloons reported no improvement in blood loss volume or need for hysterectomy. 100 A meta-analysis suggests that endovascular intervention may result in less blood loss compared with no endovascular intervention, particularly if occlusion is done at the level of the abdominal aorta, 101 but data are largely from uncontrolled studies with highly varied inclusion criteria, indications for use, and techniques for balloon inflation. 102 Ultimately, more prospective research is needed to confirm and define benefits of balloon occlusion.…”

Section: Balloon Occlusionmentioning

confidence: 99%

Placenta Accreta Spectrum

Einerson

Gilner

Zuckerwise

2023

Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

show abstract

“…Aortic balloon occlusion in PAS has been shown to reduce blood loss, transfusion requirements and increase rates of uterine conservation [ 7 , 16 , 17 ]. In contrast, internal iliac artery occlusion typically requires placement in an interventional radiology suite due to the need for selective arterial catherization and bilateral femoral artery access; it also presents radiation burden to the woman and fetus [ 18 ]; and perhaps most importantly, multiple randomized control trials have shown no benefit in reducing maternal morbidity [ [10] , [11] , [12] ].…”

Section: Discussionmentioning

confidence: 99%

Use of an aortic balloon to achieve uterine conservation in a case of placenta accreta spectrum: A case report

Bartels

Brophy

Moriarty

et al. 2023

Case Reports in Women's Health

View full text Add to dashboard Cite

The effect of prophylactic balloon occlusion in patients with placenta accreta spectrum: a Bayesian network meta-analysis

Cited by 15 publications

References 42 publications

The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis

The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis

Placenta Accreta Spectrum

Use of an aortic balloon to achieve uterine conservation in a case of placenta accreta spectrum: A case report

Contact Info

Product

Resources

About